Europe (WHO region) vs Viet Nam: Previously treated cases tested for RR-/MDR-TB
Europe (WHO region)
90.0%
in 2024
Viet Nam
100.0%
in 2024
Europe (WHO region) rank
2nd
Viet Nam rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Europe (WHO region)
- Viet Nam
How they compare
Viet Nam currently reports 100.0% against 90.0% in Europe (WHO region), a difference of 10.0%.
That makes Viet Nam's figure about 1.1 times Europe (WHO region)'s.
The two have swapped places 2 times across 12 shared years of data; in 2013 it was Viet Nam ahead.
Europe (WHO region) ranks 2nd and Viet Nam ranks 1st of 11 groups.
Across the 2 decades both report, Europe (WHO region) averaged higher in 1 and Viet Nam in 1.
Head to head by decade
| Decade | Europe (WHO region) | Viet Nam | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 65.3% | 86.1% | 20.9% | Viet Nam |
| 2020s | 93.8% | 93.6% | 0.2% | Europe (WHO region) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Europe (WHO region) or Viet Nam?
- Viet Nam, at 100.0% against 90.0% in Europe (WHO region) as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Europe (WHO region) and Viet Nam?
- 10.0%, with Viet Nam ahead.
- How many years of comparable data are there for Europe (WHO region) and Viet Nam?
- 12 years are reported by both, from 2013 to 2024.
- How do Europe (WHO region) and Viet Nam rank globally for previously treated cases tested for rr-/mdr-tb?
- Europe (WHO region) ranks 2nd and Viet Nam ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.